Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
04/2012
04/03/2012CA2435466C Use of il-18 inhibitors for the treatment and/or prevention of heart disease
04/03/2012CA2434930C Treating pulmonary disorders with gaseous agent causing repletion of gsno
04/03/2012CA2432792C Methods for modulating tumor growth and metastasis
04/03/2012CA2398445C A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
03/2012
03/29/2012WO2012040595A2 Administration of serine protease inhibitors to the stomach
03/29/2012WO2012040511A2 Compounds that modulate intracellular calcium
03/29/2012WO2012040465A2 Multipotent stem cells and uses thereof
03/29/2012WO2012040137A1 Oxadiazole inhibitors of leukotriene production
03/29/2012WO2012039460A1 Substituted amide compound
03/29/2012WO2012038922A1 Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions
03/29/2012WO2012038058A1 Treatment of conditions by toll-like receptor modulators
03/29/2012WO2012037834A1 5α-ANDROSTANE (ALKYL)-3β,5,6β-TRIOL INJECTION AND PREPARATION METHOD THEREFOR
03/29/2012WO2011146560A3 Use of jasmonates for treating heart failure and related cardiac disorders
03/29/2012WO2011116282A3 Nicotinic acetylcholine receptor agonists
03/29/2012WO2011071951A3 N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
03/29/2012WO2011071947A3 Bis-acylated hydroxylamine derivatives
03/29/2012WO2011010084A8 Cyclosporin conjugates
03/29/2012US20120077876 Method For Improved Bioactivation Of Pharmaceuticals
03/29/2012US20120077870 Materials and Methods for the Treatment of Pathological Neovascularization in the Eye
03/29/2012US20120077866 Antisense modulation of c-reactive protein expression
03/29/2012US20120077865 Methods for treating hypercholesterolemia
03/29/2012US20120077857 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors
03/29/2012US20120077856 Pharmaceutical product
03/29/2012US20120077855 Crystalline tripeptide epoxy ketone protease inhibitors
03/29/2012US20120077853 Human protein tyrosine phosphatase inhibitors and methods of use
03/29/2012US20120077847 Alpha-ketoamide derivatives useful endothelial lipase inhibitors
03/29/2012US20120077830 Caspase inhibitors and uses thereof
03/29/2012US20120077829 Parenteral solutions containing metolazone
03/29/2012US20120077828 Chemical compounds
03/29/2012US20120077826 [6,5] - bicyclic gpr119 g protein-coupled receptor agonists
03/29/2012US20120077817 Novel pharmaceutical compositions of ranolazine
03/29/2012US20120077815 Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors
03/29/2012US20120077812 Bicyclic compounds and use as antidiabetics
03/29/2012US20120077808 Niacin Mimetics, and Methods of Use Thereof
03/29/2012US20120077807 Niacin mimetics, and methods of use thereof
03/29/2012US20120077795 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/29/2012US20120077794 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/29/2012US20120077793 Compounds for the Treatment of Metabolic Disorders
03/29/2012US20120077789 Method for treatment of diseases
03/29/2012US20120077787 Organic compounds
03/29/2012US20120077775 Macrocyclic compounds useful as inhibitors of kinases and hsp90
03/29/2012US20120077771 Compositions for use in cardioplegia comprising esmolol and adenosine
03/29/2012US20120077763 METHODS FOR TREATING HEART FAILURE BY INHIBITING THE MITOCHONDRIAL SODIUM-CALCIUM EXCHANGER (mNCE)
03/29/2012US20120077762 Compositions and methods for the prevention and treatment of heart failure
03/29/2012US20120077761 Compositions and methods for the prevention and treatment of coronary heart diseases
03/29/2012US20120077750 Use of a growth-stimulating protein
03/29/2012US20120077734 Methods and assays for treating conditions in which macrophages play a pathogenic role
03/29/2012US20120077733 Antagonists against interaction of pf4 and rantes
03/29/2012US20120077732 Cyclic peptides and uses thereof
03/29/2012US20120076878 Compositions and methods for the prevention and treatment of brain diseases and conditions
03/29/2012US20120076877 Pharmaceutical compositions comprising extracts of sarcopoterium spinosum, components thereof, and uses thereof
03/29/2012US20120076863 Nanoparticulate stabilized anti-hypertensive compositions
03/29/2012US20120076856 Orodispersible pharmaceutical composition of perindopril
03/29/2012US20120076833 Surface-oriented antibody coating for the reduction of post-stent restenosis
03/29/2012US20120076823 Vector
03/29/2012US20120076819 Compositions And Methods For Treating of Microbial Infections
03/29/2012US20120076808 Combined antigen and dna vaccine for preventing and treating autoimmune diseases
03/29/2012US20120076799 Antagonists of pcsk9
03/29/2012US20120076796 Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
03/29/2012US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/29/2012US20120076786 Bispecific antibodies
03/29/2012US20120076774 Detection and/or treatment of diseases associated with autoantibodies
03/29/2012US20120076773 Novel Drug Delivery Devices
03/29/2012US20120076760 Compositions and methods of vascular injury repair cross-reference to related applications
03/29/2012US20120076754 Use of IL-17 Polypeptides for Use in the Prevention or Treatment of Atherosclerosis
03/29/2012US20120076742 Topical drug delivery system with dual carriers
03/29/2012US20120076730 Peptides for transport of therapeutics and their carriers in mouse models and humans
03/29/2012DE102010046837A1 Phenylchinazolinderivate Phenylchinazolinderivate
03/29/2012CA2813268A1 Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions
03/29/2012CA2812299A1 Administration of serine protease inhibitors to the stomach
03/29/2012CA2810706A1 Substituted amide compound
03/29/2012CA2809646A1 5.alpha.-androstane-3.beta.,5,6.beta.-triol injection and preparation method therefor
03/28/2012EP2434017A2 Identification of a micro-RNA that activates expression of beta-myosin heavy chain
03/28/2012EP2433630A1 Self-emulsifying composition of 3 fatty acid
03/28/2012EP2433496A1 Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
03/28/2012EP2432765A1 Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
03/28/2012EP2432493A1 Use of il-17 polypeptides for use in the prevention or treatment of atherosclerosis
03/28/2012EP2432489A2 Variants of c-type natriuretic peptide
03/28/2012EP2432486A1 Compositions comprising compounds from palm oil mill effluents for use in the prevention and treatment of cardiovascular diseases
03/28/2012EP2432470A1 Treatment of heart failure with normal ejection fraction
03/28/2012EP2432328A1 Fat blends and uses thereof
03/28/2012EP2252612B1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors
03/28/2012EP1951690B1 Heterocyclic cetp inhibitors
03/28/2012EP1894919B1 Heterocyclic compound having type i 11 beta hydroxysteroid dehydrogenase inhibitory activity
03/28/2012EP1799199B1 Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure
03/28/2012EP1679058B1 Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases
03/28/2012EP1308438B9 3-substituted urea derivatives and medicinal use thereof
03/28/2012EP1117689B1 Bone morphogenetic protein antagonists based on the mature protein
03/28/2012CN1762341B Salvianolic acid compound for treating cardiovascular and cerebrovascular disease and liver disease, and application thereof
03/28/2012CN102395589A Fused pyrrolopyridine derivative
03/28/2012CN102395557A Kinase inhibitor compounds
03/28/2012CN102395364A Pharmaceutical compositions
03/28/2012CN102395355A Particle size-structured parenteral dispersions
03/28/2012CN102391346A Oleanane saponin compounds and purpose thereof
03/28/2012CN102391336A Compound and preparation method and use thereof
03/28/2012CN102391258A Amino-substituted flavone compound and preparation and use thereof
03/28/2012CN102391250A Dabigatran compound and preparation method and medicinal composition thereof
03/28/2012CN102391209A Mesylate cinepazide crystal form II and preparation method thereof
03/28/2012CN102391192A Preparation method and application of shikimic acid ligustrazine
03/28/2012CN102391160A Metformin and 2,5-dihydroxybenzene sulfonate, and compound recipe composition thereof
1 ... 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 ... 1595